- Home
- CLRB vs GIFT Comparison
CLRB vs GIFT Comparison
Compare CLRB & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLRB | GIFT |
|---|---|---|
| Founded | 2002 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.5M | 22.0M |
| IPO Year | 2008 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CLRB | GIFT |
|---|---|---|
| Price | $1.18 | $0.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | 148.1K | ★ 248.3K |
| Earning Date | 11-12-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 52.05 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $83,181,716.00 |
| Revenue This Year | N/A | $6.02 |
| Revenue Next Year | N/A | $8.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.12 | $0.43 |
| 52 Week High | $4.70 | $1.29 |
Technical Indicators
Market Signals| Indicator | CLRB | GIFT |
|---|---|---|
| Relative Strength Index (RSI) | 25.04 | 42.33 |
| Support Level | N/A | $0.44 |
| Resistance Level | $3.03 | $1.07 |
| Average True Range (ATR) | 0.16 | 0.11 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 12.69 | 32.11 |
Price Performance
Historical ComparisonAbout CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About GIFT RDE Inc.
Giftify Inc operates in the incentive and rewards industry with a focus on retail, dining, and entertainment experiences, as the owner and operator of digital platforms, CardCash.com, Restaurant.com, and Takeout7.com. CardCash.com is a secondary gift card exchange platform, allowing consumers and retailers to buy and sell gift cards at various scales from several retailers; Restaurant.com is a restaurant-focused digital deals brand, connecting digital consumers and businesses by offering dining, retail, and entertainment deal options at several restaurants and retailers; and Takeout7 is a restaurant technology company offering online ordering solutions and AI-powered digital marketing services. Giftify has one segment, the sale of gift cards and discount certificates to its customers.